Results 271 to 280 of about 129,974 (285)
Some of the next articles are maybe not open access.
Clinical Obstetrics & Gynecology, 2011
Endometrial cancer is the most common gynecologic malignancy in the United States. The majority of women are diagnosed with early-stage, low-grade endometrioid tumors that are highly curable with primary surgery. Patients with more advanced and/or higher grade disease require multimodality therapy and have a higher risk for recurrence. Although uterine
Marcela G. del Carmen +2 more
openaire +3 more sources
Endometrial cancer is the most common gynecologic malignancy in the United States. The majority of women are diagnosed with early-stage, low-grade endometrioid tumors that are highly curable with primary surgery. Patients with more advanced and/or higher grade disease require multimodality therapy and have a higher risk for recurrence. Although uterine
Marcela G. del Carmen +2 more
openaire +3 more sources
Lymphadenectomy in endometrial cancer
The Lancet, 2009Not ...
Uccella, S. +3 more
openaire +2 more sources
Endometrial cancer and fertility
Current Opinion in Obstetrics & Gynecology, 2006Endometrial cancer can affect reproductive-age women who may desire fertility preservation. This article discusses the current, available data about conservative management of endometrial cancer in young women.Reproductive-age women with well differentiated endometrial carcinoma have an overall favorable prognosis provided that the tumor is identified ...
Beth W. Rackow, Aydin Arici
openaire +2 more sources
Pharmacotherapy of endometrial cancer
Expert Opinion on Pharmacotherapy, 2009Endometrial cancer is the seventh most common malignancy among women worldwide. Despite most cases being diagnosed at an early stage, the death rate has increased steadily over the past 20 years. The lack of an effective, standardized adjuvant treatment for women at a high risk of recurrence has contributed to these disappointing results.The goal of ...
Nicanor I. Barrena Medel +4 more
openaire +3 more sources
Screening for endometrial cancer
Medical Journal of Australia, 2003Routine screening for endometrial carcinoma is currently not justified. Postmenopausal women need to be educated about the importance of seeking attention if any vaginal bleeding occurs. All postmenopausal bleeding requires review and appropriate investigation.
openaire +3 more sources
Prevention of Endometrial Cancer
JAMA: The Journal of the American Medical Association, 1977To the Editor.— It was a welcome relief to read Lipsett's article, "Estrogen Use and Cancer Risk" (237:1112), in which he supports the thesis that estrogens per se are not carcinogenic but are "preparative" for the development of cancer. There is little doubt that the cause of endometrial cancer is some carcinogenic agent (a virus or some other ...
openaire +3 more sources
Obesity and Endometrial Cancer
2016Endometrial cancer is the sixth most common cancer in women worldwide and the most common gynecologic malignancy in the developed world. This chapter explores the current epidemiologic evidence on the association between obesity and endometrial cancer risk and mortality.
Christine M. Friedenreich +3 more
openaire +3 more sources
Management of endometrial cancer
American Journal of Obstetrics and Gynecology, 1996Preoperative assessment requires only endometrial sampling for diagnosis. Curettage is needed when endometrial sampling is unsatisfactory. Transvaginal ultrasonography may be useful in screening high-risk patients, as well as in assessing myoinvasion or cervical extension. Postsurgical pathologic prognostic factor analysis is most accurate in assigning
openaire +3 more sources